Belatacept and Kidney Transplant Video Gallery
The Food and Drug Administration (FDA) has approved the drug Nulojix (belatacept) for the prevention of graft rejection after kidney transplants. In this kidney transplant video, Christian P. Larsen, Emory University, provides a nutshell explanation of how the transplant drug works, how it might impact kidney transplant patients and what type of work went into the drug's development. The immunosuppressive drug belatacept can better preserve kidney function in kidney transplant recipients while preventing graft rejection when compared with the standard drug cyclosporine.
New Transplant Drug Belatacept: How It Works
Christian P. Larsen, Emory University, provides a nutshell explanation of a breakthrough in transplant medicine.
Transplant Drug Belatacept Shows Promise for Kidney Transplant
Christian P. Larsen, Emory University, explains why Belatacept represents a breakthrough in transplant medicine.
New Transplant Drug Belatacept: Drug Research and Development
Christian P. Larsen, Emory University, on the years of work that resulted in FDA approval of Belatacept, a breakthrough in transplant medicine.
